Andrew J. D'Silva - 21 Aug 2025 Form 3 Insider Report for OptimizeRx Corp (OPRX)

Role
Chief Business Officer
Signature
/s/ Marion Odence-Ford, by Power of Attorney
Issuer symbol
OPRX
Transactions as of
21 Aug 2025
Net transactions value
$0
Form type
3
Filing time
07 Oct 2025, 11:25:15 UTC
Next filing
07 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
D'Silva Andrew J. Chief Business Officer C/O OPTIMIZERX CORPORATION, 260 CHARLES STREET, SUITE 302, WALTHAM /s/ Marion Odence-Ford, by Power of Attorney 06 Oct 2025 0002083717

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OPRX Common Stock 37,097 21 Aug 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OPRX Stock Option 21 Aug 2025 Common Stock 6,993 $7.20 Direct F2
holding OPRX Stock Option 21 Aug 2025 Common Stock 40,000 $67.31 Direct F3
holding OPRX Stock Option 21 Aug 2025 Common Stock 13,018 $15.04 Direct F4
holding OPRX Stock Option 21 Aug 2025 Common Stock 5,892 $12.73 Direct F5
holding OPRX Stock Option 21 Aug 2025 Common Stock 13,723 $4.95 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 24,890 shares of common stock underlying unvested restricted stock units ("RSUs") granted under OPRX's equity incentive plans. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of OPRX common stock. The RSUs vest as follows: (i) 8,000 RSUs which represent the 4th and 5th installments of Mr. D'Silva's 9/1/2021 grant, these installments vest ratably on 9/1/2025 and 9/1/2026; (ii) 2,217 RSUs which represent the final installment of Mr. D'Silva's 10/3/2022 grant, which installment vests on 10/3/2025; (iii) 3,928 RSUs which represent the 3rd and 4th installments of Mr. D'Silva's 12/19/2023 grant, which installments vest ratably on 12/19/2025 and 12/19/2026; (iv) 3,472 RSUs which will vest in 3 equal annual installments beginning on 10/1/2025, which is the 1st anniversary of the grant date; and (v) 7,273 RSUs which will vest in three equal annual installments beginning on 12/11/2025, which is the 1st anniversary of the grant date.
F2 The stock option vests in three equal annual installments beginning October 1, 2025, which was the first anniversary of the grant date.
F3 The stock option vests in three equal annual installments beginning September 1, 2022, which was the first anniversary of the grant date.
F4 The stock option vests in three equal annual installments beginning October 3, 2023, which was the first anniversary of the grant date.
F5 The stock option vests in three equal annual installments beginning December 19, 2023, which was the first anniversary of the grant date.
F6 The stock option vests in three equal annual installments beginning December 11, 2024, which was the first anniversary of the grant date.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person